Fosfomycin Tromethamine Granule, For Solution
Product Images NDC 69097-579

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosfomycin Tromethamine (NDC 69097-579). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (066fd4fd 2c6d 477c A342 92f05fe6b0f4 01)

FDA Label Image

Fosfomycin-label (066fd4fd 2c6d 477c A342 92f05fe6b0f4 02)

Fosfomycin-label (066fd4fd 2c6d 477c A342 92f05fe6b0f4 02)
This single-dose sachet contains 3 grams of fosfomycin tromethamine and other inactive ingredients such as flavors, saccharin, and sucrose. The package lacks child resistance and should be kept away from children. The product should be stored at 25°C and can be kept within 15°C to 30°C. The manufacturer is Cipla Ltd., Kurkumbh, India, and the product is manufactured for Cipla USA, Inc. The provided ID does not give any information.*
FDA Label Image

Carton-fosfomycin (066fd4fd 2c6d 477c A342 92f05fe6b0f4 03)

Carton-fosfomycin (066fd4fd 2c6d 477c A342 92f05fe6b0f4 03)
This is a medication description for Fosfomycin Tromethamine Granules for Oral Solution, which comes in a single-dose sachet containing 3 grams of the medication. Instructions for dosing, administration, and storage are provided. Improvements in symptoms should be seen within 2 to 3 days, with healthcare provider contact recommended if symptoms do not improve by the fourth day. The medication is manufactured by Cipla and distributed by Cipla USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.